Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors

OBJECTIVES: Inhibitors to the checkpoint proteins cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4) and programmed cell death protein 1 (PD‐1) are becoming widely used in cancer treatment. However, a lack of understanding of the patient response to treatment limits accurate identification of pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Bornschlegl, Svetlana, Gustafson, Michael P, Delivanis, Danae A, Ryder, Mabel, Liu, Minetta C, Vasmatzis, George, Hallemeier, Chris L, Park, Sean S, Roberts, Lewis R, Parney, Ian F, Jelinek, Diane F, Dietz, Allan B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082708/
https://www.ncbi.nlm.nih.gov/pubmed/33968403
http://dx.doi.org/10.1002/cti2.1267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082708/
https://www.ncbi.nlm.nih.gov/pubmed/33968403
http://dx.doi.org/10.1002/cti2.1267

Ejemplares similares